Back to Journals » Drug Design, Development and Therapy » Volume 8

Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy

Total article views   Abstract views HTML views PDF downloads Totals
11,410 Dovepress* 10,392 654+ 960 11,046
PubMed Central* 0 364 119 364
Totals 10,392 1,018 1,079 11,410
*Since 21 October 2014
+Since July 2016

View citations on PubMed Central and Google Scholar